Artiva Biotherapeutics
Artiva Biotherapeutics is a NK Cell Therapies for Cancer founded in 2019.
2
Funding Rounds
$198.0m
Money raised
Funding
Funding series
Funding Series Analysis
The company Artiva Biotherapeutics has raised a total of $198m in funding over 2 rounds.
Key Insights:
- Artiva Biotherapeutics funding round, March 2021: $120m
- Artiva Biotherapeutics Series A round, June 2020: $78m
Artiva Biotherapeutics funding round, March 2021
$120m
Artiva Biotherapeutics Series A round, June 2020
$78m
Industries
Artiva Biotherapeutics is active in the following industries:
- Biotechnology
- Engineering
- Oncology
- Tissue engineering
- Allogeneic cell therapy
- Biomedical engineering
- Cancer immunotherapy
- Regenerative medicine
- Cell therapy
- Immunotherapy
- Healthcare